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Type I, or invariant natural killer T cells (iNKT 
cells) are an evolutionary conserved population 
of lymphocytes (Bendelac et al., 2007). Mouse 
iNKT cells express a semi-invariant TCR en-
coded by a V14-J18 rearrangement, whereas 
humans express an orthologous V24 segment 
also with an invariant rearrangement to J18 
(Bendelac, 1995; Bendelac et al., 2007). iNKT 
cells are reactive to CD1d, a nonclassical MHC 
class I antigen–presenting molecule. Unlike MHC 
class I antigen–presenting molecules, which are 
encoded by highly polymorphic genes and which 
present peptides, CD1d is part of the nonpoly-
morphic CD1 gene family whose proteins are 
specialized for presenting various lipids (Brigl 
and Brenner, 2004). The antigens are bound to 
CD1 molecules with the lipid backbone inside a 
hydrophobic binding groove that is formed be-
tween two antiparallel helices that sit above an 
antiparallel -sheet platform. The glycolipid head 
group, typically a carbohydrate, is presented at 
the CD1 surface for interaction with the TCR 
(Moody et al., 2005; Zajonc and Kronenberg, 
2007; Godfrey et al., 2010).
iNKT cells respond well to glycosphingo-
lipids (GSLs) presented by CD1d, including the 
model synthetic antigen -galactosylceramide 
(-GalCer)  and  microbial  antigens  such  as 
-galacturonosylceramide (GalA-GSL) from 
Sphingomonas spp. bacteria (Kawano et al., 1997; 
Kinjo et al., 2005). They also recognize an 
-galactosyl diacylglycerolipid (-GalDAG), 
called BbGL-2c, from Borrelia burgdorferi (Kinjo 
et al., 2006), which is the causative agent of 
Lyme disease. These glycolipids share a molecular 
pattern, in which a hexose sugar is linked to a 
lipid backbone, either ceramide or diacylglycerol, 
via an -glycosidic bond. The CD1d antigen–
binding groove has two large pockets, A and F. 
Although GSLs bind in a conserved orientation 
in the CD1d-binding groove, with the fatty acid 
chain always inserted into the A pocket and the 
sphingosine chain accommodated within the F 
pocket, binding of diacylglycerol-based ligands 
is more flexible. We recently showed that that 
the A pocket favors binding of a C18:1 mono-
unsaturated fatty acid of borrelial -GalDAG. 
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Invariant natural killer T cells (iNKT cells) rapidly produce effector cytokines. In this study, we 
report the first crystal structures of the iNKT cell T cell receptor (TCR) bound to two natural, 
microbial glycolipids presented by CD1d. Binding of the TCR induced CDR3-–dependent 
structural changes in the F roof of CD1d; these changes resemble those occurring in the 
absence of TCR engagement when the highly potent synthetic antigen -galactosylceramide 
(-GalCer) binds CD1d. Furthermore, in the Borrelia burgdorferi –galactosyl diacylglycerol–
CD1d complex, TCR binding caused a marked repositioning of the galactose sugar into an 
orientation that closely resembles -GalCer. The TCR-dependent reorientation of the sugar, 
together with the induced CD1d fit, may explain the weaker potency of the microbial 
antigens compared with -GalCer. We propose that the TCR of iNKT cells binds with a 
conserved footprint onto CD1d, regardless of the bound glycolipid antigen, and that for 
microbial antigens this unique binding mode requires TCR-initiated conformational changes.
© 2010 Li et al.  This article is distributed under the terms of an Attribution–Non-
commercial–Share Alike–No Mirror Sites license for the first six months after the 
publication date (see http://www.rupress.org/terms). After six months it is avail-
able under a Creative Commons License (Attribution–Noncommercial–Share Alike 
3.0 Unported license, as described at http://creativecommons.org/licenses/by-
nc-sa/3.0/).
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peptide MHC-restricted TCRs, which show a high degree of 
plasticity in the receptor–ligand interface (Pellicci et al., 2009). 
Instead, the iNKT cell TCR binds in a lock and key mode and 
is therefore considered to display innate-like properties.
iNKT cells are important for the clearance of microbes that 
have antigens for the invariant TCR (Kinjo et al., 2005, 2006; 
Mattner et al., 2005; Tupin et al., 2008), although the affinity 
of these natural antigens for the invariant TCR is reduced 
50–500-fold compared with the binding to -GalCer com-
plexes with mCD1d (Wang et al., 2010). The structural basis 
of microbial antigen recognition and the reasons for the de-
creased TCR affinity for these antigens remain unknown. In 
this study, we address these issues by determining the crystal 
structures of two of the known microbial antigens, Sphingomonas 
GalA-GSL and B. burgdorferi BbGL-2c, in ternary complexes 
with mCD1d and the semi-invariant TCR. Our data demon-
strate a conserved binding mode with significant conforma-
tional changes induced by the TCR that explains the weaker 
TCR affinity of the natural antigens.
RESULTS
Overall structures
To address the structural basis for microbial glycolipid antigen 
recognition by mouse iNKT TCRs, we have determined the 
crystal structures of ternary complexes with Sphingomonas 
GSL antigen, mCD1d–GalA-GSL–TCR, and B. burgdorferi dia-
cylglycerol antigen, mCD1d–BbGL-2c–TCR, at a resolution 
of 2.74 Å and 2.8 Å, respectively (Fig. 1 and Table I). Both 
complex structures are highly similar overall to the mCD1d–
-GalCer–TCR complex structure previously described 
Depending on the position of the glycerol to which this fatty 
acid is attached, either sn-1 or sn-2, the glycolipid can bind in 
opposite orientations in the CD1d groove, which can greatly 
affect antigenicity because of a drastically different presenta-
tion of the sn-3–linked sugar head group (Wang et al., 2010).
Although crystal structures of human CD1a, -b, and -d, as 
well as mouse CD1d (mCD1d) in complex with different 
glycolipids exist (Moody et al., 2005; Zajonc and Kronenberg, 
2007, 2009; Zajonc and Wilson, 2007), -GalCer is the only 
antigen that has been crystallized bound to both mouse and 
human CD1d, as well as in complex with the iNKT cell TCR 
(Koch et al., 2005; Zajonc et al., 2005a; Borg et al., 2007; 
Pellicci et al., 2009). The crystal structures of the mouse and 
human TCR ternary complexes revealed an evolutionarily 
conserved binding mode, where the TCR adopts a unique, par-
allel orientation above the CD1d molecule, unlike the more 
commonly found diagonal footprint for peptide MHC-restricted 
TCRs (Rudolph et al., 2006). Although the TCR- chain is 
situated directly above the opening to the CD1d-binding 
groove, perfectly positioned to interact with the galactose and 
polar regions of -GalCer, the TCR- chain is offset to the 
C-terminal end of the 1 helix of CD1d, above the closed 
end of F pocket of CD1d. As a result, the complementarity-
determining regions (CDRs) of the TCR- chain primarily 
interact with the glycolipid (CDR1- and CDR3-), whereas 
the TCR- chain forms contact through CDR2- with CD1d 
residues. CDR3- does not interact with the antigen but, 
instead, modulates the TCR affinity (Mallevaey et al., 2009). 
The TCR of V14 iNKT undergoes no conformational 
changes in the CDR loops upon antigen binding, unlike classical 
Figure 1.  Recognition of microbial glycolipids by the iNKT cell TCR. (A) Structure of the TCR bound to mCD1d–GalA-GSL. (B) Structure of the TCR 
bound to mCD1d–BbGL-2c. (A and B) GalA-GSL is shown in green; BbGL-2c is shown in yellow; mCD1d heavy chain and 2m are shown in gray; TCR  
chain is shown in cyan; TCR  chain is shown in orange. (C) Chemical structures of -galactosyl–containing sphingolipids (-GalCer and GalA-GSL) and 
diacylglycerolipid BbGL-2c.JEM VOL. 207, October 25, 2010 
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viously reported counterclockwise orientation (Wu et al., 
2006). In that binding orientation, the fatty acid does not form 
the typical kink as is observed for the BbGL-2c ligand (Fig. 2). 
The reason for the different binding modality of the fatty acid 
in the A pocket of mCD1d is currently unknown, but it 
does not appear to alter the overall position of the lipid back-
bone inside the mCD1d groove. In the ternary complex with 
BbGL-2c, the sn-1–linked oleic acid was bound inside the A 
pocket and sn-2–linked palmitic acid in the F pocket, similar 
to the mCD1d–BbGL-2c complex in the absence of the TCR 
(Wang et al., 2010). Overall, the better-defined and unbiased 
electron density for both ligands after TCR binding suggests 
that upon TCR engagement, the polar moieties of both 
ligands are locked in a rigid binding orientation, whereas 
each ligand bound to CD1d only is slightly more flexible, re-
sulting in less well-defined electron density (Wu et al., 2006; 
Wang et al., 2010).
Comparison of the complexes with and without the TCR
Previously, the structure of the mCD1d–PBS25 complex, which 
is an analogue of -GalCer with an eight-carbon instead of 
(Pellicci et al., 2009): the iNKT cell TCR docks parallel to the 
CD1d-binding cleft, with the  chain above the F pocket 
(Fig. 1). Only the TCR  chain contacts the glycolipid (dis-
cussed in detail in TCR–lipid interaction and the TCR foot-
print), whereas the  chain forms conserved contacts with 
CD1 residues, mainly through CDR2-. In addition, the 
unique CDR3- of the TCR used in this study also forms con-
tacts with CD1d (Table S1). The electron densities corre-
sponding to both glycolipid ligands, especially for the polar 
moieties, are surprisingly very well defined, in contrast to pre-
vious structures determined in the absence of bound TCR 
(Fig. 2 and Fig. S1; Wu et al., 2006; Wang et al., 2010).   
In both structures, the electron density fully engulfs the 
galactose or galacturonic head groups, as well as the lipid back-
bones. As reported previously for GSL antigens (Zajonc and 
Wilson, 2007), the fatty acid and sphinganine tails of GalA-GSL 
are inserted into the A and F pockets, respectively. The pal-
mitic acid spacer lipid, previously found in the A pocket of 
the mCD1d–GalA-GSL complex (Wu et al., 2006), was not 
observed here. Instead, the shorter fatty acid (C14:0) is inserted 
straight into the A pocket in a clockwise rather than the pre-
Table I.  Data collection and refinement statistics
Data collection and refinement statistics mCD1d–BbGL-2c–TCR mCD1d–GalA-GSL–TCR
Data collection
Space group C2221 C2221
Cell dimensions
a, b, c (Å) 78.00, 188.37, 149.79 78.93, 191.24, 151.21
, ,  (°) 90.00, 90.00, 90.00 90.00, 90.00, 90.00
Resolution range (Å) 40.0–2.80 [2.90–2.80] 50.0–2.74 [2.84–2.74]
Number of reflections 27,545 29,275
Rmerge (%) 11.7 [64.1] 10.4 [46.4]
Multiplicity 7.3 [7.4] 5.5 [5.5]
Average I/I 19.7 [3.0] 15.3 [2.7]
Completeness (%) 99.9 [99.9] 95.9 [97.5]
Refinement
Number of atoms 6,599 6,606
Protein 6,413 6,371
Ligand 53 48
Carbohydrate 80 80
Waters 53 107
R/Rfree 0.203/0.259 0.198/0.253
Ramachandran plot
Favored (%) 96.6 96.7
Allowed (%) 99.8 100.0
RMSDs
Bonds (Å) 0.008 0.012
Angles (°) 1.13 1.43
B-factors
Protein (Å2) 48.0 41.4
Ligand (Å2) 63.7 26.3
Carbohydrate (Å2) 68.5 56.1
Waters (Å2) 40.8 33.7
Numbers in brackets refer to the highest resolution shell.2386 Induced fit by invariant TCR | Li et al.
TCR–lipid interaction and the TCR footprint
To compare TCR recognition of the different antigens, the 
interactions between TCR and the three ligands were analyzed 
(Fig. 4 and Table S1). In each of the three complexes, the 
2 hydroxyl of the galactose forms an H bond with Gly96- 
of CDR3-, whereas the 3 and 4 hydroxyl groups H bond 
to Asn30- of CDR1-. However, note that the H bond 
between the 4 OH of GalA-GSL and N30- is 3.7 Å, which 
slightly exceeds the maximal distance (3.5 Å) for typical H bonds. 
TCR residue Arg95- (CDR3-) H bonds with the 3 hy-
droxyl of the sphingosine chain in -GalCer and GalA-GSL 
ternary structures, whereas in the BbGL-2c complex, this moi-
ety is not present. As a result, although both -GalCer and 
GalA-GSL form four H bonds with the TCR, BbGL-2c forms 
only three and, as such, therefore may interact less avidly with 
the TCR.
The presentation modes of the three ligands in the ternary 
complexes could be compared by superimposing the three 
structures. Even though the three ligands have different con-
formations when bound to mCD1d, they are adjusted into 
almost identical positions above the mCD1d-binding groove 
when the TCR is bound (Fig. 4 D; maximum root mean 
square deviation [RMSD] of 1.1 Å between all carbohydrate 
moieties). Comparing the three lipids, the conformation of 
GalA-GSL shows very little change when interacting with the 
TCR. These data suggest that this lipid is displayed in an op-
timized position in the binding groove of mCD1d, although 
the electron density in the TCR uncomplexed structure was 
the least defined. Therefore, GalA-GSL binding to mCD1d 
may be the most flexible, or alternatively, the ligand occu-
pancy was not close to 100%, suggesting that there was still some 
endogenous ligand bound to mCD1d, which would affect 
the interpretation of the electron density map (Wu et al., 2006). 
The overall orientations of the TCR’s six CDR loops on the 
surface of mCD1d were compared when viewed from the 
side of the TCR (Fig. 4 E). All of the three CDR- loops and 
CDR1- and CDR2- loops adopt almost identical confor-
mations (RMSDs <0.5 Å in pairwise comparisons of the C 
atoms). However, the CDR3- loop in the -GalCer struc-
ture is partially disordered and not aligned with the two 
microbial lipid structures. This conformation difference is not 
due to the difference of TCR recognition footprint but a re-
sult of different CDR3- usage. The TCR in the complex of 
-GalCer has a different CDR3- sequence (CASGDAG-
GNYAEQFF), which results in a 3-aa-longer CDR3- loop, 
compared with the V14V8.2 TCR from the 2C12 hybrid-
oma used in this study (CASGDEGYTQYF). Not surprisingly, 
our TCR has a higher affinity toward mCD1d–-GalCer 
(KD = 11 nM instead of KD = 29–69 nM; Pellicci et al., 2009; 
Wang et al., 2010), as the CDR3- loops form additional 
contacts, including one salt bridge with CD1d (Table S1). Over-
all, the converged glycolipid conformations and TCR foot-
print reveal a highly conserved TCR recognition pattern, even 
for antigens that initially bind in a different orientation to 
mCD1d. In conclusion, the TCR has the capacity to reorient 
antigens to a preferred position for a conserved interaction, 
C26:0 fatty acid chain, has been determined (Zajonc et al., 
2005a). Likewise, the structure of the mCD1d–-GalCer–TCR 
ternary complex, with the GSL antigen having the full C26:0 
fatty acid chain, has also been determined (Pellicci et al., 
2009). We compared three pairs of mCD1d complex struc-
tures to evaluate the position of the different glycolipid anti-
gens, -GalCer, GalA-GSL, and BbGL-2c, binding to mCD1d 
before and after interacting with the TCR (Fig. 3). Upon 
TCR binding to -GalCer, the head group of -GalCer is 
shifted by 1 Å toward the 1 helix, as reported previously 
(Pellicci et al., 2009). Interestingly, GalA-GSL has very 
minimal conformational change upon TCR binding. How-
ever, BbGL-2c shows the most significant change upon inter-
acting with the TCR. The galactose moiety tilts toward the 
2 helix by 30° (angle of the glycosidic bond), and further-
more, rotates 60° in a clockwise orientation when viewed from 
above. This causes the 6 OH group to point toward the 1 
helix instead of the 2 helix. Consequently, the 2 and 3 ga-
lactose hydroxyl groups are moved closer to the 2 helix to 
form H bonds with Asp153 of mCD1d, as has been observed 
for -GalCer and for GalA-GSL, even without bound TCR. 
In contrast, the 2 OH loses an H bond to Arg79 because it 
moves away from the 1 helix. Overall, BbGL-2c forms less 
extensive H bonds than either -GalCer or GalA-GSL and 
has the biggest repositioning of the galactose group upon 
TCR binding, which involves the breaking of two H bonds, 
together with the loss of several van der Waals interactions 
(involving in particular residues Phe70, Tyr73, and Ser76 of 
mCD1d) while forming four new polar interactions.
Figure 2.  Electron density maps for the microbial glycolipids.  
(A–D) Representation of the final 2Fo-Fc maps drawn around glycolipids 
GalA-GSL (A and C) and BbGL-2c (B and D) from the ternary mCD1d–
glycolipid–TCR complexes. The maps are contoured at 1  and shown as a 
blue mesh in side view (A and B) and looking down into the binding 
groove from the top (C and D). Hydrophobic mCD1d residues interacting 
with the lipid backbone and charged residues contacting the polar  
moieties of the glycolipid sugar are depicted. The 2 helix is removed  
for clarity in A and B. Relative positions of TCR CDR1-, CDR3-, and 
CDR3- are depicted for general orientation in A and B.JEM VOL. 207, October 25, 2010 
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[M1s1]; Kd = 1.45 × 103 [s1]) and the lowest affinity for 
mCD1d–BbGL-2c complexes (KD = 6.2 µM; Ka = 0.216 × 105 
[M1s1]; Kd = 0.165 [s1]). GalA-GSL has an intermediate 
binding to the invariant TCR, with a KD of 0.69 µM (Ka = 
1.43 × 105 [M1s1]; Kd = 0.094 [s1]; Wang et al., 2010). 
Both -GalCer and GalA-GSL have similar fast TCR associ-
ation rates, likely because of the relatively little reorientation 
of the glycoepitope of these antigens by the TCR (Fig. 3, A 
and B). In contrast, binding of the TCR to mCD1d–BbGl-2c 
is much slower, as the TCR has to reorient the BbGl-2c head 
rather than exhibiting a plasticity in ligand recognition, which 
would have resulted in slightly different CDR loop confor-
mations and possibly a variable binding footprint.
A preformed F roof may modulate TCR affinity
Previously, we have reported the equilibrium binding kinetics 
of the V14V8.2 TCR used in this study for mCD1d 
loaded with -GalCer, GalA-GSL, or BbGL-2c (Wang et al., 
2010). The TCR shows the highest binding affinity for 
mCD1d–-GalCer complexes (KD = 11 nM; Ka = 1.3 × 105 
Figure 3.  Comparison of -GalCer, GalA-GSL, and BbGL-2c binding to mCD1d before and after TCR binding. (A–C) H-bond interactions  
between glycolipids and mCD1d in a front (top) and top view (bottom). mCD1d–glycolipid structures before TCR binding are shown in cyan. In each of the 
three ternary complexes, mCD1d is labeled in gray, and glycolipids are shown in sticks and different colors. -GalCer is shown in orange; GalA-GSL is 
shown in green; BbGL-2c is shown in yellow. H bonds are illustrated as blue dashed lines with distances labeled in angstroms.
Figure 4.  Interactions of the TCR with 
mCD1d-presented glycolipids. (A–C) H-bond 
interactions between the mCD1d-bound  
glycolipids and the TCR are depicted as blue 
dashed lines with distances labeled in ang-
stroms. The CDR1- and CDR3- regions are 
shown in cyan. -GalCer is shown in orange; 
GalA-GSL is shown in green; BbGL-2c is 
shown in yellow. The side chains of residue 
N30-, G96-, and R95- that make contact 
with the glycolipids are shown. (D) Compari-
son of the glycolipids in the ternary complex 
structures after superimposition. Glycolipids 
are shown in sticks. (E) Comparison of foot-
prints of the TCR on the surface of mCD1d. 
CDR loops are labeled and colored identically 
to the glycolipids. Note that the H bond be-
tween the 4 OH of GalA-GSL and N30- is 
3.7 Å, which slightly exceeds the maximal 
distance (3.5 Å) for typical H bonds.2388 Induced fit by invariant TCR | Li et al.
binding (Fig. 5). As previously reported, for the mCD1d–PBS25 
complex, mCD1d forms a roof over the F pocket (F roof), 
which buries the tail of the sphingosine chain underneath 
(Zajonc et al., 2005a). Interestingly, the roof is not present 
when either GalA-GSL or BbGL-2c binds to mCD1d (Fig. 5, 
top; Zajonc et al., 2005a; Wang et al., 2010), suggesting that 
-GalCer, or in this case the short acyl chain variant PBS25, 
is exclusively able to induce structural changes above the 
F  pocket.  However,  surprisingly,  the  F  roof  also  forms 
above the two microbial ligands upon TCR binding (Fig. 5, 
bottom). Detailed structural comparison of the mCD1d struc-
ture before and after TCR binding identified major side chain 
as well as main chain movement of mCD1d residues L84, 
V149, and L150. This movement is likely induced upon 
insertion of a key TCR residue, L99 of CDR3-, into the 
mCD1d-binding groove, which acts as a hydrophobic finger 
to attract those residues through nonpolar van der Waals in-
teractions (Fig. 6). The importance of L99- has previously 
been revealed by a site mutagenesis study (Scott-Browne et al., 
2007), with an L99A substitution resulting in complete loss 
of T cell activation by -GalCer. In each of the ternary com-
plex structures, L99- was positioned right above the roof 
and directly made contact with the roof-forming residues 
through nonpolar van der Waals interactions. The side chains 
of L84, V149, and L150 were in comparable distances (be-
tween 4 and 4.5 Å) to L99- before and after TCR docked 
into the mCD1d–-GalCer complex. However, for GalA-GSL 
and BbGL-2c, the distances between the side chains of L99- 
to those of L84, V149, and L150 were >5.5 Å and shortened 
to around 4.0 Å only after TCR binding. Therefore, the roof 
formed by these three residues over the F pocket in mCD1d 
appears to be a structural feature that is required for optimal 
interaction with the TCR. -GalCer, the only glycolipid that 
induces the formation of the roof upon mCD1d binding in 
the absence of the TCR, readily endows mCD1d with an 
group to obtain the conserved interaction (Figs. 3 C and 4 E). 
Interestingly, the dissociation rate is much faster for both 
GalA-GSL and BbGL-2c, even though all three ligands bind 
in a highly similar orientation in the TCR ternary complex 
(Fig. 4 D). We have further calculated the activation energies of 
TCR binding to the various mCD1d–glycolipid complexes 
from the kinetic equilibrium binding data (Table S2). We cal-
culated the variation of the free energy standard (G°) from 
the KD and converted Ka to an activation energy standard 
(E°), similar as reported previously (Wu et al., 2002; Sidobre 
et al., 2004). The comparison, calculated as E° normalized 
by G° and expressed as phi () values, allowed us to in-
vestigate the effect of the different glycolipids moieties on the 
initial association phase. A  value of 0 indicates that the 
contact is not formed in the transition state nor participates in 
the initial association, whereas contacts for which values are 
higher are involved in the initial interaction. As GalA-GSL 
has a  value close to 0, the GalA-GSL modifications appear to 
have no effect on the initial TCR association. Given the pe-
ripheral position of the modification at the 6 of the GalA-GSL 
sugar, this finding rules out a role for the 4-OH group of the 
-GalCer ceramide backbone (missing in GalA-GSL) in pro-
moting the initial phase of complex formation,. For BbGL-2c, 
the calculated  value of 0.28 suggests instead that the BbGL-2c 
ligand is partially involved in the transition intermediate. As 
observed for other ligands (Sidobre et al., 2004), the polar 
head is likely to be contacted first by the TCR in the initial 
association phase, and it is therefore possible that, in the case 
of BbGL-2c, it directly influences the Ka because of the need 
of the TCR to rearrange its orientation for proper binding.
To address why the TCR dissociates faster from mCD1d 
when either GalA-GSL or BbGl-2c is bound, we compared the 
molecular surfaces of each pair of mCD1d–glycolipid and 
mCD1d–glycolipid–TCR ternary structures to reveal differ-
ences in the mCD1d–glycolipid complex before and after TCR 
Figure 5.  Comparison of the mCD1d antigen–binding grooves before and after TCR binding. (A–C) Binding groove portals of mCD1d with bound 
glycolipids -GalCer (A), GalA-GSL (B), and BbGL-2c (C) before (top) and after (bottom) TCR binding. mCD1d is shown as a gray surface. Lipid antigens are 
shown as sticks, with -GalCer in orange, GalA-GSL in green, and BbGL-2c in yellow.JEM VOL. 207, October 25, 2010 
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V149, and L150 closer, narrowing the backbones of 1 and 
2 helices over the F pocket to form the F roof (Fig. 6).
For BbGL-2c, the 2 hydroxyl group of the galactose forms 
one H bond with Asp80 and another H bond with Arg79. 
However, there is only one weak H bond formed between the 
oxygen atom of the sn-2–linked fatty acid and Thr156 on the 
2 helix. Thus, the weak interaction between BbGL-2c and 
mCD1d is not able to cause induced formation of the roof. Ad-
ditionally, the head group of BbGL-2c is not positioned similar 
to -GalCer or GalA-GSL, thereby losing two crucial H bonds 
with Asp153. The interaction of the TCR with mCD1d pre-
senting BbGL-2c will induce dramatic rotation of the galactose. 
As a result, the unfavorable conformation of BbGL-2c in the 
mCD1d-binding groove results in the weakest binding affinity 
to the TCR among the three glycolipid antigens.
DISCUSSION
We have proposed that the semi-invariant TCR of iNKT 
cells is selected for the recognition of glycolipid antigens from 
pathogenic microbes, which most likely have a diacylglycerol 
rather than a ceramide lipid, as ceramides are confined to 
relatively nonpathogenic Sphingomonas spp. (Kinjo et al., 2005; 
Mattner et al., 2005; Sriram et al., 2005). However, the first 
antigen discovered, which is the most potent and also the one 
most widely used in various experimental studies and clinical 
trials, is the ceramide-containing antigen -GalCer (Kawano 
et al., 1997). Despite information on -GalCer recognition, 
the  structural  basis  for  the  TCR-mediated  recognition  of 
natural microbial antigens, including those with a diacylglyc-
erol lipid, has remained unknown. Furthermore, it has been 
optimized TCR recognition surface and thus has the highest 
binding avidity toward the TCR, in part because of the slow 
TCR dissociation. However, the microbial antigens GalA-GSL 
and BbGL-2c lack the preformed hydrophobic roof over the 
F pocket when bound inside the mCD1d groove, which is 
energetically less favorable for the recognition by the TCR, 
and therefore, they are relatively weaker antigens. The hydro-
phobic finger L99 of the TCR has to maintain the F roof, 
likely by paying an energetic penalty that leads to faster 
TCR dissociation.
The different abilities to preform the roof likely arise from 
the structural differences of the three glycolipids. GalA-GSL 
contains a sphinganine chain with a 3-OH group, whereas 
short-chain and full-length -GalCer have a phytosphingosine 
tail with both 3-OH and 4-OH groups. When -GalCer is 
bound, the three H bonds formed by both the 3-OH and 4-OH 
groups with Asp80 in the mCD1d, together with the exten-
sive H bond formed by -GalCer with the 2 helix, likely 
pull the backbone segments of 1 and 2 helices over the F' 
pocket closer toward each other. This backbone change is ac-
companied by the repositioning of the side chains of L84, V149, 
and L150, causing formation of the roof (Zajonc et al., 2005a). 
The preset favorable conformation on the mCD1d surface does 
not change when the TCR binds, and there are no further 
gross changes in the distance between the backbones of 1 
and 2 helices delineating the F pocket. GalA-GSL, which 
lacks the 4-OH group, forms only one H bond with 3-OH 
to Asp80 in the 1 helix, which appears not strong enough 
to induce the mCD1d conformational change. TCR residue 
L99- inserts into the F pocket and pulls the side chains of L84, 
Figure 6.  Comparison of the induced fit on the 1 and 2 helices caused by TCR binding. (A–C) CD1d-glycolipid structures (gray) are super-
imposed with ternary complexes after TCR binding. Interactions of TCR residue Leu99- with the side chains of Leu84, Val149, and Leu150 of mCD1d (top). 
TCR is shown in cyan; mCD1d complexed with TCR is shown in orange when presenting -GalCer (A), in green for GalA-GSL (B), and in yellow for BbGL-2c 
(C). The bottom panels show TCR view of the CD1d–glycolipid complexes (cyan) superimposed onto the CD1d–glycolipid structures after TCR binding 
(CD1d is shown in gray, and glycolipids colored as in the top panels). Van der Waals interactions are depicted as dashed lines and are labeled with dis-
tances in angstroms before (red) and after (blue) TCR binding.2390 Induced fit by invariant TCR | Li et al.
2002; Cantu et al., 2003). This suggested that there is little 
accommodation during the interaction and is consistent with 
a lock and key mechanism for TCR binding when -GalCer 
is the antigen. Furthermore, when antigens with different sugars 
but the same GSL lipid were compared, calculation of the 
differences in the activation energy suggested that the TCR 
recognizes the exposed sugar during the initial phase of the 
interaction (Sidobre et al., 2004). This agrees not only with the 
structural data indicating that the sugar is placed in the near 
optimal position for TCR interaction for both -GalCer and 
GalA-GSL but not for BbGL-2c, but also with the kinetic 
data indicating a similar Ka for the two GSL antigens but a 
much slower one for BbGL-2c.
A second, marked conformational change upon TCR 
binding observed in our study is the closing of the roof over 
the F pocket. This is likely mediated for recognition of the 
two natural microbial antigens by Leu99 in the CDR3 region 
of the TCR  chain. -GalCer binding to mCD1d uniquely 
caused this change in the absence of the TCR. The F roof 
formation has not been observed for other structurally similar 
ligands, such as OCH or the -GalCer phenyl analogues 
(Schiefner et al., 2009; Sullivan et al., 2010). However, in the 
case of OCH, a spacer molecule was described in the F pocket 
that likely prevents the roof formation. Examination of the 
electron density maps for the phenyl analogues revealed not 
interpreted electron density in the vicinity of the F roof that 
could possibly be attributed to a solvent molecule that inter-
feres with the roof formation, likely DMSO, which has also 
been observed in a similar position in the mCD1d–BbGL-2f 
structure (Wang et al., 2010). Interestingly, structural changes 
above the F pocket have previously been suggested to be in-
volved in modulating TCR affinities for a panel of -GalCer 
analogues (McCarthy et al., 2007). Because TCR interaction 
with both the mCD1d–GalA-GSL and mCD1d–BbGL-2c 
complexes has a faster Kd, we propose that although the posi-
tion of the sugar has a greater influence on the Ka, the ability 
to form the F roof independently of the TCR has a greater 
influence on TCR dissociation. This model, derived from 
our structural experiments, accounts for the intermediate KD 
of the TCR for mCD1d–GalA-GSL complexes, the weaker 
KD for mCD1d–BbGL-2c, and the observed kinetic prop-
erties of TCR binding to the different mCD1d–glycolipid 
antigen complexes.
In addition to the conserved footprint onto mCD1d, the 
TCR also has a few conserved amino acid hot spots where it 
contacts portions of the glycolipid antigen, namely the 2-, 
3-, and 4-OH groups of the galactose or galacturonic acid. 
Although all of these OH groups of the sugar participate in 
the TCR interaction, analysis of synthetic GSL compounds 
with individual positions altered indicates that the 2 position 
is most important (Wu et al., 2005; Raju et al., 2009). These 
hot spots are also maintained by the TCR in at least one other 
nonglycosidic ligand, which was suggested to be a structural 
mimetic of an incomplete galactose ring (Silk et al., 2008). As a 
result the iNKT cell epitope is not strictly limited to -anomeric 
galactose and structurally related sugars, but can also contain 
uncertain why complexes of these microbial antigens with 
mCD1d have a KD for the TCR that is 50–500-fold re-
duced compared with -GalCer (Wang et al., 2010). In this 
study, we have addressed these important issues by determin-
ing the three dimensional structures of two natural microbial 
antigens in ternary complexes with mCD1d and the TCR of 
iNKT cells.
Although the glycolipid antigens from Sphingomonas spp. 
and B. burgdorferi have structural similarity to the model anti-
gen -GalCer, at least in terms of having a hexose sugar in 
-linkage to a lipid with two aliphatic chains, their binding 
orientation to mCD1d was previously shown to be different, 
most notably for the borrelial -GalDAG antigen BbGL-2c 
(Wang et al., 2010). Therefore, it is surprising that, upon TCR 
binding to the mCD1d–glycolipid complexes, most TCR 
contacts are conserved among all three structures. Furthermore, 
comparison of the crystal structures of those glycolipid anti-
gens bound to mCD1d before and after TCR binding enabled 
us to gain insight into the mechanism of TCR recognition, 
including the remarkable capability of the TCR to reorient 
suboptimally bound glycolipids to obtain the conserved ori-
entation of the sugar and the TCR footprint on mCD1d. 
Unexpectedly, for the diacylglycerol-based glycolipid BbGL-2c, 
the TCR apparently is able to induce the breaking of existing 
H bonds between the glycolipid and mCD1d while enabling 
the formation of new H bonds after a repositioning of the 
glycolipid in the mCD1d antigen–binding groove. This re-
flects the increased flexibility of binding of glycerol-based 
antigens within the groove of mCD1d. Consistent with this 
flexibility, we have previously observed two distinct bind-
ing modes for closely related, synthetic -GalDAG antigens 
that were based on the structure of material purified from 
B. burgdorferi (Wang et al., 2010). These two antigens can 
bind with their glycolipid backbones oriented 180° rotated from 
one another inside the mCD1d-binding groove. The orien-
tation depends on the fatty acids linked to the sn-1 and sn-2 
positions of the glycerol (Wang et al., 2010), with the prefer-
ence of the mCD1d A pocket for monounsaturated C18:1 fatty 
acids over fully saturated or diunsaturated fatty acids. The dif-
ferent orientations lead to different presentations of the galactose 
head group, with a nonantigenic glycolipid placing it rotated 
120° away from the ideal position. It is likely that the TCR 
has a limit in its capacity to reorient the galactose moiety of 
such an antigen to be able to interact and bind in a conserved 
footprint, rendering it incapable of stimulating iNKT cells.
In contrast, with diacylglycerol antigens, the ceramide back-
bones of GSLs are bound in one orientation, with the sphin-
gosine in the F pocket and sugar exposed in a more favorable 
orientation for carbohydrate presentation and TCR binding 
to the CD1d glycolipid complex. Therefore, it is not surpris-
ing that the most potent iNKT cell antigens contain ceramide 
backbones rather than diacylglycerol moieties. This more 
optimal placement of GSL antigens is in agreement with the 
results from earlier surface plasmon resonance–based studies, 
which indicated little temperature dependence in the binding 
of the TCR to mCD1d–-GalCer complexes (Sidobre et al., JEM VOL. 207, October 25, 2010 
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gen, binds to mCD1d, they could form the basis for rational 
drug design of more potent antigens for activating human 
iNKT cells.
MATERIALS AND METHODS
Protein expression and purification. Fully glycosylated mCD1d protein 
and V14/V8.2 TCR were expressed and purified as described previously 
(Zajonc et al., 2005b; Wang et al., 2010). In brief, mCD1d was secreted 
from 5 liters of baculovirus-infected SF9 (Spodoptera frugiperda 9) insect cells 
(2 × 106 cells/ml) in shaking flasks (145 rpm) at 28°C after 3 d of infection 
at a multiplicity of infection of approximately three. SF9 cells were spun down 
(1,000 g for 10 min at 4°C), and the media were further concentrated to 
0.4 liter and exchanged against PBS buffer using tangential flow-through fil-
tration (Millipore). The protein was purified from the concentrated media by 
Ni2+ affinity chromatography (using His-Bind Fractogel; EMD) in 50 mM 
Tris-HCl, pH 8.0, buffer followed by anion-exchange chromatography using 
MonoQ HR 10/10 (GE Healthcare) in 10 mM Tris-HCl buffer at pH 8.0 
with a linear gradient of 0–250 mM NaCl.
For TCR refolding, inclusion bodies of the  and  chains were dis-
solved in 50 mM Tris-HCl, 5 mM EDTA, 2 mM DTT, and 6 M guanidine-
HCl, pH 7.0, and stored at 80°C. 32 mg of  chain and 48 mg of  chain 
were thawed, mixed, pulsed with 1 mM DTT, and then added drop wise to 
1 liter of refolding buffer (50 mM Tris-HCl, 0.4 M l-Arg, 5 M urea, 2 mM 
EDTA, 5 mM reduced glutathione, 0.5 mM oxidized glutathione, and 0.2 mM 
PMSF, pH 8.0, at room temperature) under constant stirring at 4°C. After 
16 h, the same amount of  and  chains was added again and continued to 
stir for an additional 8 h. The refolding mix was then dialyzed overnight 
against 18 liters of 10 mM Tris-HCL, 0.1 M urea, pH 8.0, and then again for 
8 h against the same fresh buffer. Finally the refolding mix was dialyzed 
against 18 liters of 10 mM Tris-HCl, pH 8.0, for 24 h. The refolded TCR 
was either centrifuged for 30,000 g for 10 min or directly filtered through 
0.22-µm filter. DEAE Sepharose beads (GE Healthcare; 5 ml settled resin) 
were added to the dialyzed refolding mix and stirred for 2–4 h at 4°C. DEAE 
beads were collected with a 40–60-µm Buchner funnel, washed with 10 mM 
Tris-HCl, pH 8.0, and transferred to an Econo column (Bio-Rad Laborato-
ries). The refolded TCR was eluted with 100 mM NaCl in 10 mM Tris-
HCl, pH 8.0, diluted fourfold with 10 mM Tris-HCl, pH 8.0, and injected 
into a MonoQ 5/50 GL (GE Healthcare). The TCR was eluted using a linear 
NaCl gradient (0–300 mM NaCl). TCR-containing fractions were pooled, 
concentrated, and further purified by size-exclusion chromatography using a 
Superdex S200 10/300 GL (GE Healthcare).
Glycolipid  loading  and  ternary  complex  formation.  The  synthetic 
GalA-GSL was dissolved at 3 mg/ml in DMSO. The B. burgdorferi diacylglyc-
erolipid (BbGL-2c) was dissolved in 0.5% Tween and 0.9% NaCl at a concen-
tration of 0.22 mg/ml. mCD1d was incubated overnight with 3–6 M excess of 
GalA-GSL and BbGL-2c in the presence of 0.05% Tween 20 and 100 mM 
Tris-HCl, pH 7.0, respectively. GalA-GSL–loaded CD1d protein was then 
incubated with equimolar amounts of TCR for 30 min at room temperature, 
and the ternary mCD1d–GalA-GSL–TCR complex was isolated by size-
exclusion chromatography using a Superdex S200 10/300 GL. BbGL-2c–loaded 
CD1d was purified by size-exclusion chromatography first and then incubated 
with the same amount of TCR for 30 min without further purification. Both 
the complexes were concentrated to 4 mg/ml for crystallization.
Crystallization and structure determination. Crystals of both mCD1d–
glycolipid–TCR complexes were grown at 22.3°C by sitting drop vapor 
diffusion while mixing 0.5 µl of protein with 0.5 µl of precipitate (18% poly-
ethylene glycol 3350 and 0.2 M ammonium citrate dibasic for GalA-GSL; 
20% polyethylene glycol 3350 and 0.1 M citrate, pH 5, for BbGL-2c). Crystals 
were flash-cooled at 100 K in mother liquor containing 20% glycerol. Dif-
fraction data were collected at the Stanford Synchrotron Radiation Laboratory 
beamline 7.1 and processed with the HKL2000 software suite (Otwinowski 
and Minor, 1997). The mCD1d–GalA-GSL–TCR crystal belongs to space 
group C2221 with cell parameters a = 79.0 Å, b = 191.2 Å, and c = 151.2 Å. 
other polar moieties that maintain those conserved contacts 
upon TCR engagement.
The conserved TCR footprint has first been suggested based 
on site-directed mutagenesis experiments of the individual 
TCR CDR residues, which affected structural related glyco-
lipids to a similar degree (Scott-Browne et al., 2007). However, 
this study did not include the borrelial -GalDAG ligand, 
which binds differently to mCD1d compared with -GalCer. 
A subsequent study revealed differences in the contributions 
of different CDR- and - region amino acids in the activa-
tion of T cell hybridomas when -GalCer and -GalDAG 
were compared (Florence et al., 2009). This was proposed to be 
caused by a different contribution of those TCR residues to 
antigen binding, suggesting a different orientation of the sugar 
of -GalDAG when bound to mCD1d or induced confor-
mation of mCD1d. However, in light of the structures pre-
sented in this study, we propose that those residues are likely 
important instead for facilitating the reorientation of the 
galactose moiety of -GalDAG to give the conserved ori-
entation. It appears that the TCR–CD1d contact interface 
has been optimized during the course of evolution and that 
those conserved hot spot interactions outweigh the steric 
hindrances caused by suboptimally bound ligands to the 
extent possible.
However, it has not formerly been demonstrated that this 
conserved footprint is also true for a complex -anomeric 
carbohydrate–containing antigen, the self-antigen isoglobotri-
hexosyl ceramide (iGb3). However, the unique binding mode 
of the TCR of iNKT cells, being off-set to the C-terminal 
end of the 1 helix combined with a slight vertical tilt, opens 
an escape hatch between CDR1- and the A roof of CD1d, 
through which longer antigens can escape. As the structure of 
iGb3 bound to mCD1d illustrates, those ligands would clash 
with the TCR, assuming the conserved footprint (Zajonc et al., 
2008). However, previous modeling attempts (Zajonc et al., 
2008), as well as recent data on -anomeric forms of iGb3 (Yin 
et al., 2009), suggest that -linked glycolipids will be, to the 
extent possible, flattened by the TCR to mimic the -anomeric 
glycolipid pattern, while possibly conserving those TCR hot 
spots on the ligand, and further by exposing the elongated 
head group through the escape hatch. However, how speci-
ficity for the terminal galactose of iGb3 can then be retained 
is currently unknown, but it could entail specific binding to 
either CD1d for a more stable conformation or interaction with 
framework residues of the TCR, as no CDR is close enough 
for direct interaction. Likewise, the mechanism for TCR 
recognition by some cultured human iNKT cells for lyso-
phosphatidylcholine presented by human CD1d (Fox et al., 
2009) remains to be determined, and this could involve an 
entirely different contact point and/or footprint on CD1d.
In summary, we have demonstrated an unanticipated de-
gree of structural changes induced by the TCR in complexes 
of two microbial glycolipids bound to mCD1d. These changes 
involve the sugar moiety of the antigen itself and mCD1d 
amino acids in the roof over the F pocket. Because these 
changes are preformed when -GalCer, the most potent anti-2392 Induced fit by invariant TCR | Li et al.
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with cell parameters a = 78.0 Å, b = 188.4 Å, and c = 149.8.2 Å.
The asymmetric unit contains one mCD1d–glycolipid–TCR molecule 
with an estimated solvent content of 56.9% for GalA-GSL and 55.3% for 
BbGl-2c complex. The structures were determined by molecular replacement 
using MOLREP as part of the CCP4 suite (Collaborative Computational 
Project Number 4, 1994; Vagin and Teplyakov, 1997) using the protein co-
ordinates from the mCD1d-iGB3 structure (Protein Data Bank ID 2Q7Y; 
Zajonc et al., 2008), followed by the variable domain of the mouse V14V8.2 
TCR (Pellicci et al., 2009) and, finally, the constant domain (from PDB ID 
3HE6) as the search model. The molecular replacement solution with the 
complete TCR revealed that the constant domain was slightly tilted in both 
of our structures. After the molecular replacement solution was obtained 
containing both mCD1d and TCR, the model was rebuilt into A-weighted 
2Fo-Fc and Fo-Fc difference electron density maps using the program COOT 
(Emsley and Cowtan, 2004). The final refinement steps were performed 
using the TLS (translation, libration, and screw axis) procedure in REFMAC 
(Winn et al., 2001) with five anisotropic domains (1-2 domain of CD1d, 
including carbohydrates and glycolipid, 3 domain, 2M, variable domain, 
and constant domain of TCR). The mCD1d–GalA-GSL–TCR structure 
was refined to 2.74 Å with a final Rcryst and Rfree of 19.8% and 25.3%, re-
spectively. The mCD1d–BbGL-2c–TCR structure was refined to 2.8 Å 
with a final Rcryst and Rfree of 20.3% and 25.9%, respectively. The quality of 
the model was examined with the program Molprobity (Lovell et al., 2003).
Protein Data Bank accession numbers. Coordinates and structure factors 
for the mCD1d–BbGL-2c–V14 TCR and mCD1d–GalA-GSL–TCR ter-
nary complexes have been deposited in the Protein Data Bank under acces-
sion codes 3O9W and 3O8X, respectively.
Online supplemental material. Fig. S1 depicts omit maps for the glyco-
lipid ligands, as well as electron density for the CDR residues of the TCR. 
Table S1 shows a list of contacts formed between CD1d, glycolipid, and 
TCR. Table S2 contains activation energies that were calculated from previ-
ously published surface plasmon resonance data (Wang et al., 2010). Online 
supplemental material is available at http://www.jem.org/cgi/content/full/ 
jem.20101335/DC1.
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